GLP-1 + DPP-4 Concurrent Use : Detects concurrent use of GLP-1 medications and DPP-4 inhibitors
Another thing to watch for is murky labeling issues, since some companies describe their compounded GLP-1 formulas as generics. This is misleading, since generic drug formulas are FDA-regulated and must meet the same ingredient, safety, dosing, manufacturing, and quality standards as their brand-name counterparts
Lustig (born 1957) is an American pediatric endocrinologist
For guidance specific to your individual health situation, consult your healthcare provider
They are also more vulnerable to dehydration and electrolyte imbalances, both of which contribute to palpitations
Not recommended for persons under 18 years of age, pregnant or breastfeeding women, and people with increased nervous excitability, insomnia or arterial hypertension